Brent Addington
Ray M. Allen, Jr.
Louis Caruso
Yaser Cheema
Mark A. Coppess
Jiang Cui
Todd D. Edwards
Jay Gardner
Richard Gordon
Steven S. Gubin
Paul Hess
David H. Holloway, Jr.
Jason Infeld
Christopher P Ingelmo
Eric E. Johnson
Jeffrey E. Kerlan
James E. Klemis
David H. Kraus
David Lan
Amit Malhotra
Justin May
Frank A. McGrew, III
Jennifer S. Morrow
Daniel Otten
Dharmesh S. Patel
Basil M. Paulus
William L. Russo
Holger P. Salazar
Joseph K. Samaha
Arsalan Shirwany
Stacy C. Smith
Darrell Sneed
Larry B. Spiotta
Bunker Stout
Arie Szatkowski
David C. Wolford
Jawwad Yusuf
Gilbert Zoghbi
7/23/2017
 
Gilbert Zoghbi, M.D., FACC, FSCAI
Gilbert Zoghbi

M.D., FACC, FSCAI




Professional Interests General cardiology, interventional cardiology (complex coronary interventions, peripheral vascular and carotid interventions, percutaneous PFO/ASD closure, aortic valvuloplasty), nuclear cardiology, echocardiography.
Title Interventional Cardiologist
Stern Cardiovascular Foundation  
Hospital Appointments
  • Baptist Memorial Hospital, Memphis, TN, 12/11-present
  • Baptist Memorial Hospital, DeSoto, MS, 12/11-present
  • Methodist Hospital, Germantown, TN, 12/11-present
Clinical Responsibilities /Affiliations
  •  Interventional cardiologist, Stern Cardiovascular Foundation, 3/12-present
  • Interventional cardiologist, Memphis Heart Clinic, 12/11-2/12
  • Attending general and interventional cardiologist, UAB hospital, 2008-2011
  • Attending general and interventional cardiologist, BVAMC, 2008-2011
  • Attending in echocardiography, UAB and BVAMC, 2003-2011
  • Director, Cardiac Catheterization Laboratory, BVAMC, 2009-2011
  • Director, Interventional Fellowship Training Program, UAB, 2009-2011
  • Director, Chest Pain Center, UAB hospital, 2010-2011
  • Consulting Cardiologist, UAB Hospital and The Kirklin Clinic, 2004-2011
  • Attending cardiologist, UAB hospital, 2003-2007
  • Attending cardiologist, BVAMC, 2003-2007
  • Director, Cardiac Care Unit, BVAMC, 2003-2007  
Education
  • 1988-1992 Bachelor of Sciences in Biology, American University of Beirut
  • 1992-1996 Medical Doctor, American University of Beirut
Medical Licensure
  • Alabama License, No 23540, 2000-2011
  • Mississippi License, No 21802, 2011-present
  • Tennessee License, No 47876, 2011-present
  • ACLS Certification, 1997- present
Board Certification
  • 2000-2010 American Board of Internal Medicine (ABIM)
  • 2003-2012 ABIM Cardiovascular Disease
  • 2004-2014 Certification Board of Echocardiography
  • 2004-2014 Certification Board of Nuclear Cardiology
  • 2008-2018 ABIM lnterventional Cardiology
  • 2010-2019 The American Board of Vascular Medicine (ABVM), Diplomate in Endovascular Medicine
Post-Doctoral Training
  • 1996-1997 Internal Medicine Residency PGY1 American University of Beirut
  • 1997-2000 Internal Medicine Residency PGY1-PGY3 Good Samaritan Hospital, Baltimore Johns Hopkins University Affiliate
  • 1999-2000 Internal Medicine Residency Chief Medical Resident Good Samaritan Hospital, Baltimore Johns Hopkins University Affiliate
  • 2000-2003 Cardiovascular Disease Fellowship University of Alabama at Birmingham
  • 2007-2008 lnterventional Cardiology Fellowship University of Alabama at Birmingham
Additional Training
  • 2007 Levels II & Ill Cardiac CT Huntsville Heart Center
Academic Appointments
  • 2011 Associate Professor of Medicine, University of Alabama at Birmingham
  • 2010-2011 Director, Chest Pain Center, University of Alabama at Birmingham
  • 2010-2011 Scientist, Center for Cardiovascular Biology, University of Alabama at Birmingham
  • 2009-2011 Director, lnterventional Cardiology Fellowship Program, University of Alabama at Birmingham
  • 2009-2011 Director, Cardiac Catheterization Laboratory, Birmingham VA Medical Center
  • 2003-2011 Assistant Professor of Medicine, University of Alabama at Birmingham
  • 2003-2007 Director, Cardiac Care Unit, Birmingham VA Medical Center
Awards/Honors
  • Undergraduate:
    American University Beirut
    Dean's Honor List, 1989-1991
  • Postgraduate:
    Outstanding Intern, American University of Beirut, 1996-1997
    Outstanding Intern, Good Samaritan Hospital, 1997-1998
    Outstanding Junior Resident, Good Samaritan Hospital, 1998-1999
    Winner “3rd Annual Doctors’ Dilemma Program”, 1999, (competition among all training
    hospitals in Baltimore)
    Outstanding Senior Resident, Good Samaritan Hospital, 1999-2000
    Winner 2nd Scientific Poster Prize, Maryland ACP, 2000
    Aventis Cardiology Fellow Scholarship, 2001
    Nominee for the University of Alabama at Birmingham Outstanding Visitor Scholar Award, 2003
    Winner of the 2003-2004 American Society of Nuclear Cardiology/Amersham Health, Inc. Clinical Research Award in Nuclear Cardiology, 2003
    Winner of the 8th American Society of Nuclear Cardiology Symposium and Scientific Session Fujisawa travel grant award, 2003
  • Post-Fellowship:
    Finalist, Northwestern Cardiovascular Young Investigators' Forum, Chicago, 2006
    Recognition Award: In Recognition of Your Support and Dedication to the Cardiology Fellows, UAB Fellows, 2006- 2007
Professional Societies/Memberships
  • Society for Cardiovascular Angiography and Interventions
  • Society for Vascular Medicine
  • American Heart Association
  • American College of Cardiology
  • American Society of Echocardiography
  • American Society of Nuclear Cardiology
Professional Societies' Titles
  • 2005-present Fellow of the American College of Cardiology (FACC)
  • 2009-present Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI)
Committees Local
  • 2009-2011 Division of Cardiovascular Disease Advisory Committee, University of Alabama at Birmingham
  • 2009-2011 Department of Medicine Education Committee, Fellowship Directors Subcommittee, University of Alabama at Birmingham
  • 2009-2011 Fellowship Advisory I Selection Committee, Division of Cardiovascular Disease, University of Alabama at Birmingham
  • 2008-2011 Quality assurance committee for the cardiac catheterization laboratory at the University of Alabama at Birmingham
  • 2006-2011 Institutional Board Review Committee, Birmingham VA Medical Center
  • 2004-2007 Radiation Safety Committee Member, Birmingham VA Medical Center
Committees National
  • 2011-present SCAt Transradial Committee
National Writing Committees
  • Member of the Writing Committee: Reassessment of the Validity of the Universal Definition for Ml following Coronary Revascularization (SCAt, 2011).
  • Member of the Writing Committee: SCAt Radial Best Practices Statement. (SCAt, 2011)
University Activities
  • 2010-present Director, Chest Pain Center, University of Alabama at Birmingham
  • 2009-present Director, lnterventional Cardiology Fellowship Program, University of Alabama at Birmingham
Editorial Board MembershipThe Open Cardiovascular Imaging Journal, elected 10/2008
Peer Reviewer Journals
  • American Journal of Cardiology
  • Echocardiography, A Journal of Cardiovascular Ultrasound and Allied Techniques
  • Heart
  • American Journal of Medical Sciences
  • Journal of Nuclear Cardiology
  •  Journal of Invasive Cardiology
  • Acute Cardiac Care
Major Research Interests
  • Industry sponsored clinical research trials in the field of interventional cardiology.
  • Outcomes research in percutaneous interventions.
Teaching Experience

Didactic Lectures: CCU Morning Report, UAB Department of Medicine
(One hour didactic lectures for medical students and house staff while on the cardiology ward service)

  • Evaluation and management of valvular heart disease, 9/2008
  • Adult congenital heart disease, 11/2008
  • The basics of right heart catheterization,2/2009
  • Evaluation and management of unstable angina and non STEMI, 3/2009
  • Adult congenital heart disease, 3/2009
  • Acute coronary syndromes, 4/2009
  • Introduction to peripheral vascular disease, 4/2009
  • Introduction to peripheral vascular disease, 5/2009
  • Adult congenital heart disease, 8/2009
  • Adult congenital heart disease, 9/2009
  • Adult congenital heart disease, 11/2009
  • Unstable angina, 12/2009
  • Adult congenital heart disease, 12/2009
  • Unstable angina, 2/2010
  • lnterventional cardiology, 5/2010
  • Valvular heart disease, 8/20/2010
  • Acute Ml, 9/22/2010
  • Adult congenital heart disease, 11/12/2010
  • Valvular heart disease, 11/24/2010

Introductory Cardiology Fellows' Lecture Series, UAB Division of Cardiovascular Disease
(One hour didactic lectures for cardiovascular disease fellows)

  • How to prepare for the cardiology board, 8/2004
  • lnotropes, pressors and vasodilators, 8/2004
  •  lnotropes, pressors and vasodilators, 8/2004
  • Rest Myocardial Perfusion Imaging, 4/2006
  • lnotropes, pressors and vasodilators, part 1, 8/2006
  • lnotropes, pressors and vasodilators, part 2, 10/2006
  • lnotropes, pressors and vasodilators, part 1, 8/2008
  • lnotropes, pressors and vasodilators, part 2, 9/2008
  • Management of chronic stable angina, 3/2009
  • Invasive physiologic assessment of coronary lesions, 5/2009
  • Introduction to the Cath Lab Part 1, 8/2009
  •  lnotropes, pressors and vasodilators, 8/2009
  •  Introduction to the Cath Lab Part 2, 8/2009 
  • Introduction to the Cath Lab Part 3, 9/2009
  • Introduction to the Cath Lab Part 4, 9/2009
  • Principles of Radiation Safety in the Cath Lab, 10/2009
  • Introduction to the Cath Lab Part 1, 8/2010
  • Introduction to the Cath Lab Part 2, 8/2010
  • Introduction to the Cath Lab Part 3, 9/2010
  • Introduction to the Cath Lab Part 4, 9/2010
  • Introduction to the Cath Lab Part 5, 1/2011

Director and Moderator of the Cardiac Catheterization Noon Conferences, UAB Division of Cardiovascular Disease, 9/2009-present.
(Biweekly conferences for cardiovascular disease fellows: didactic lectures, case presentations and review of literature)

lnterventional Rounds, UAB Section of lnterventional Cardiology
(One hour didactic lectures to interventional cardiology fellows)

  • Balloon angioplasty and stenting: the basics, 8/2008
  • Antiplatelet therapy in the cath lab, part 1, 9/2008
  • Antiplatelet therapy in the cath lab, part 2, 9/2008
  • Hemodynamic evaluation of coronary artery lesions, 10/2008
  • Complications in the cath lab, 11/2008
  • The basics of intravascular ultrasound part 1, 4/2009
  • The basics of intravascular ultrasound part 2, 5/2009
  • Balloon angioplasty and stenting: the basics, 7/2009
  • Antiplatelet therapy in the cath lab, part 1, 8/2009
  • Antiplatelet therapy in the cath lab, part 2, 8/2009
  • Complications in the cath lab, 9/2009
  • Balloon angioplasty and stenting: the basics, 7/2010
  • Hemodynamic evaluation of coronary artery lesions part 1, 2/2011
  •  Hemodynamic evaluation of coronary artery lesions part 2, 2/2011
  • The basics of intravascular ultrasound part 1, 3/2011
  • The basics of intravascular ultrasound part 2, 3/2011
Supervision and Teaching Activities

lnterventional Cardiovascular Disease Fellows:

  • Cardiac catheterization laboratory at UAB, 2008-present

Cardiovascular Disease Fellows

  • Cardiology consult service at UAB (2 week rotations), 2004-present
    7/2004-6/2005: 1 rotation, 7/2006-6/2007: 1 rotation
  • Cardiology ward service at UAB (2 week rotations), 2008-present
    7/2008-6/2009: 6 rotations, 7/2009-6/2010: 6 rotations, 7/2010-1/2011: 5.5 rotations
  • CCU rotation at the BVAMC (2 week rotations), 2004-2007, 2008-present
    7/2004-6/2005: 8.5 rotations, 7/2005-6/2006: 9 rotations, 7/2006-6/2007: 9.5 rotations,  7/2008-6/2009: 7 rotations, 7/2009-6/2010: 4 rotations, 7/2010-1/2011: 2 rotations
  • Cardiac catheterization laboratory at UAB (1 day/week), 2008-present
  • Cardiac catheterization laboratory at BVAMC (4 days/week), 2004-2007, 2008-present
  • Echocardiography laboratory at BVAMC (1/2 day session/week), 2004-2007
  • Outpatient cardiology clinics at BVAMC (1/2 day sessions/week), 2004-2007, 2008- present

Internal Medicine Housestaff and Medical Students

  • Cardiology consult service at UAB (2 week rotations), 2004-present, 7/2004-6/2005: 1 rotation, 7/2006-6/2007: 1 rotation
  • Cardiology ward service at UAB (2 week rotations), 2008-present, 7/2008-6/2009: 6 rotations, 7/2009-6/2010: 6 rotations, 7/2010-1/2011:5.5 rotations
  • CCU rotation at the BVAMC (2 week rotations), 2004-2007, 2008-present, 7/2004-6/2005: 8.5 rotations, 7/2005-6/2006: 9 rotations, 7/2006-6/2007: 9.5 rotations, 7/2008-6/2009: 7 rotations, 7/2009-6/2010: 4 rotations, 712010-1/2011: 2 rotations

Preceptor to Medical Students

  • Introduction to Clinical Medicine 2 (ICM) 2004-2005 
  • Introduction to Clinical Medicine 2 (ICM) 2005-2006
  • Introduction to Clinical Medicine 1 (ICM) 2004-2005 
  • Introduction to Clinical Medicine 1 (ICM) 2005-2006
  • Introduction to Clinical Medicine 1 (ICM) 2008-2009
Major Lectures and Visiting Professorships
  • Alabama Chapter ACC Annual Meeting. Case Presentations, June 1, 2003, Sandestin . -Florida
  • Cardiology Grand Rounds, UAB. To brew or not to brew: that is the question. The effect of caffeine on adenosine myocardial perfusion imaging, June 8, 2005
  • Cardiology Grand Rounds, UAB. The widow maker, June 9, 2010
  • Baptist DeSoto Heart symposium. What to do in the office with CHF, February 25, 2012
  • Rhodes College, Memphis. Know your numbers, April 12, 2012
Grant Support/Research

Grant Support:
Abbott Fund Cardiovascular Training Fellowship Grant

  • Agency: Abott
  • Period: 7/2010-6/2011
  • Amount: $ 40,000
  • Principal investigator: Gilbert Zoghbi MD

Grant Support:
Effect of Caffeine On Ischemia Detection By Adenosine SPECT Perfusion Imagin

  • (Winner of the 2003-2004 American Society of Nuclear Cardiology/Amersham
  •  Health, Inc. Clinical Research Award in Nuclear Cardiology).
  • Agency: Fujisawa
  • Period: 2003-2004
  • Amount: $ 25,000
  • Principal Investigator: Gilbert Zoghbi, MD
Clinical Trials (Active))
  • The USpella Registry:
    a multi-site, observational registry for collection of deidentified data for patients treated with the IMPELLA ® 2.5 Percutaneous Cardiac
    Support System.
    Agency: Abiomed, Inc
    Years: 11/2010-present
    Local Principal investigator: Gilbert Zoghbi, MD (UAB)
  • BOSS CIN:
    Evaluation of Sodium Bicarbonate to Reduce Contrast-Induced Nephropathy (CIN) in Subjects with Advanced Chronic Kidney Disease (CKD) who are Undergoing Angiography.
    Agency: MD Scientific, LLC
    Years: 11/2010-present
    Local Principal Investigator: Gilbert Zoghbi, MD (UAB)
  • COMPASS:
    Coronary Obstruction Detection by Molecular Personalized Gene Expression.
    Agency: CardioDx, Inc)
    Local Principal Investigator: Ami lskandrian, MD (UAB)
    Role: Co-Investigator
  • CYPRESS, P09-6301, DAPT and Non-DAPT:
    A prospective, randomized, multicenter, double-blind trial to assess the effectiveness and safety of different durations of dual anti-platelet therapy (DAPT} in subject undergoing percutaneous coronary intervention with the CYPHER Sirolimus-eluting coronary stent.
    Agency: Cordis Corporation
    Years: 8/2009-present
    Local Principal Investigator: Vijay Misra, MD (UAB)
    Role: Co-Investigator
  • EXAMINE SYR-322: A multicenter, randomized, double-blind, placebo-controlled study to evaluate cardiovascular outcomes following treatment with Alogliptin and addition to standard of care in subjects with Type 2 Diabetes and Acute Coronary Syndrome
    Agency: Takeda Pharmaceutical Company
    Years: 9/2009-present
    Local Principal Investigator: Brigitta Brott, MD (UAB)
    Role: Co-Investigator
  • The SIRIUS TRIAL
    Agency: Cordis Corporation
    Years: 07/15/04-12/31/15
    Local Principal Investigator: Brigitta Brott, MD (UAB)
    Role: Co-Investigator
  • GRAVITAS: Gauging Responsiveness with a VerifyNow Assay -Impact on Thrombosis and Safety
    Agency: Accumetrics, Inc.
    Years: 08/25/08-08/24/13
    Local Principal Investigator: Vijay Misra, MD (UAB)
    Role: Co-Investigator
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH530348 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 - P-TIMI 50)
    Agency: Schering-Piough Corporation
    Years: 12/11/07-12/10/12
    Local Principal Investigator: Vijay Misra, MD (UAB)
    Role: Co-Investigator
  • APPRAISE 2, Protocol CV185068: Apixaban for prevention of acute ischemic events-2 A phase 3 randomized evaluation of the safety and efficacy of Apixaban in patients with a recent acute coronary syndrome
    Sponsor: Bristol-Myers Squibb
    Years: 5/2009-present
    Local Principal Investigator: Brigitta Brott, MD (UAB)
    Role: Co-Investigator
  • CRISP AMI: Counter-pulsation reduces infarct size per PCI in acute myocardial infarction. Agency: Datascope Corp.
    ears: 1/2009-present
    Local Principal Investigator: William Hillegass, MD (UAB)
    Role: Co-Investigator
  • JOMED: Jomed Jostent Coronary Stent Graft used in an emergency situation due to perforation.
    Agency: Abott Vascular
    Local Principal Investigator: William Hillegass, MD (UAB)
    Role: Co-Investigator
  • JOMED: Jomed Jostent Coronary Stent Graft used in an emergency situation due to perforation.
    Agency: Abott Vascular
    Local Principal Investigator: Gilbert Zoghbi, MD (BVAMC)
  • Radial Artery versus Saphenous Vein Grafts in Coronary Artery Bypass Agency: VA, CSP trial Local Prinicipallnvestigator: William Holman, MD (BVAMC)
    Role: Co-Investigator
Clinical Trails (Past)
  • PROTECT II: A prospective, multi-center, randomized controlled trial of the IMPELLA® RECOVER® LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI. (Highest enroller)
    Years: 11/1/2007-2/2011
    Agency: Abiomed, Inc
    Local Principal investigator: Gilbert Zoghbi, MD (UAB)
  • VA Coronary Artery Revascularization in Diabetes Study (VA CARDS), CSP # 557
    Agency: Veterans Administration
    Local Principal investigator: Gilbert Zoghbi, MD
  • A Clinical Evaluation of the XIENCE PRIME and XIENCE PRIME LL Everolimus Coronary Stent System - SPIRIT PRIME study
    Agency: Abbott Vascular
    Local Principal Investigator: Vijay Misra, MD
    Role: Co-Investigator
  • CardioMEMS Heart Sensor Allows Monitoringof Pressure to Improve Outcomes in NYHA Class Ill heart failure patients -CHAMPION trial
    Agency: CardioMEMS Inc
    Local Principal investigator: Jose Tallaj, MD
    Role: Co-Investigator
  • TC-WYRE: I.AXUS Express Stents vs. Cypher Stent: What's Your Real Life Experience? Agency: Boston Scientific
    Local Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Phase Ill Clinical Outcome Study to Examine the Long-term Safety and Efficacy of DG-031 in Reducing the Risk of Acute Cardiovascular Events by its Effect on Leuko!rienes in African American Patients with Coronary Artery Disease and Leukotriene Gene Markers. The LTCAD Study.
    Agency: deCODE Genetics
    Local Principal Investigator: Gilbert Perry, MD (BVAMC)
    Role: Co-Investigator
Investigator Initiated Research Studies
  • Outcomes of Patients Presenting with Acute Myocardial Infarction Due to Left Main Occlusion Agency: National Cardiovascular Disease Registry – NCDR Principal Investigator: Gilbert Zoghbi, MD (UAB) In-Hospital Outcomes of Patients With Low Left Ventricular Function Undergoing Rotational Atherectomy Agency: none Principal Investigator: Gilbert Zoghbi, MD (UAB)
  • Prophylactic Nitroprusside Use in Vein Graft Interventions
    Agency: None
    Principal Investigator: William Hillegass, MD (UAB)
    Role: Co-Investigator
  • Myocardial Perfusion Imaging with B-Methyl-p-[1231]-lodophenyi-Pentadecanoic Acid (BMIPP) after Transient Balloon Occlusion during Percutaneous Coronary Interventions '
    Agency: None
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Hemodynamic Evaluation of Coronary Artery Bypass Graft Lesions Using Fractional Flow Reserve
    Agency: None
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Balloon Sizing Device to Predict Renal Artery Stent Diameter and Optimal Stent Deployment Agency: Angiometrx, Inc.
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Renal Artery Stenosis: Medical Management vs. Revascularization
    Agency: Cordis.
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Myocardial Perfusion Imaging to Evaluate for Ischemia after Successful Reperfusion
    Agency: Astellas Pharma US
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Nitric Oxide Modified Lipids/Myeloperoxidase as Indicators of the Progression and Resolution of Acute Coronary Syndrome
    Agency: None
    Principal Investigator: Raed Aqel, MD (BVAMC)
    Role: Co-Investigator
  • Trends in Cardiac Rehabilitations
    Agency: None
    Principal Investigator: Gilbert Zoghbi, MD (UAB)
  • Effects of Adenosine on Brachial Artery Vasodilatation
    Agency: none
    Principal Investigator: Ami lskandrian, MD (UAB)
    Role: Co-Investigator
  • The Role of Mucomyst in Preventing Contrast Nephropathy, a Retrospective Study
    Agency: none
    Primary investigator: William Hillegass, MD (UAB)
    Role: Co-Investigator
  • Effect of insulin on isolated rat heart contractility (using Langendorff's preparation) post dobutamine with and without L-NMMA (Nitric oxide synthase blocker)
    Agency: Johns Hopkins University
    Years: 8/98-10/98
    Principal Investigator: Joshua Hare, MD
    Role: Co-Investigator
  • Effect of proadifen (Cyt P450 blocker) and glibenclamide (ATP dependent K channel blocker) on isolated rat heart contractility post dobutamine and isoproterenol with and without bradykinin and L-NMMA.
    Agency: Johns Hopkins University
    Years: 8/98-10/98
    Principal Investigator: Joshua Hare, MD
    Role: Co-Investigator
Bibliography: Manuscripts (In chronological order)  
Published Consensus Papers
Published Peer-Reviewed Original Research Papers
  • Aqel RA, Zoghbi GJ, Baldwin SA, Abo Auda WS, Calhoun DA, Coffey CS, Perry GJ, lskandrian AE. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens 2003; 21(6):1157-1162.
  • Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, lskandrian AE. Prognostic value of myocardial perfusion imaging in predicting outcome after renal trasnplantation. Am J Cardiol2003;92(2):146-151.
  • Zoghbi GJ, Patel A, Ershadi R, Heo J, Bynon J, lskandrian A. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol2003;92(9):1066-1071. 
  • Zoghbi GJ, Sanderson B, Breland J, Adams C, Schumann C, Bittner V. Optimizing risk stratification in cardiac rehabilitation with inclusion of a comorbidity and risk factor index. J Cardiopulm Rehabil2004;24(1):8-13. (Featured as the continuing education article of the J Cardiopulm Rehabil issue and was commented on by an editorial by Tom LaFontaine titled "The Complexities of Predicting Risk in CVR Patients" pages 16-18.)
  • Aqel RA, Zoghbi GJ, Trimm JR, Baldwin SA, lskandrian AE. Effect of caffeine administered intravenously on intracoronary administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiel 2004; 93(3):343-346.
  • Benza RL, Zoghbi GJ, Tallaj J, Brown R, Kirklin JK, Hubbard M, Rayburn B, Foley B, McGiffin D, Pinderski LJ, Misra V, Bourge RC. Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coli Cardiol 2004;43:1973- 1981.
  • Mehta D, Baweja G, Venkataraman R, Zoghbi GJ, Htay T, Heo J, Nanda NC, lskandrian AE. Relation between effects of adenosine on brachial artery reactivity and perfusion pattern in patients with known or suspected coronary artery disease. Am J Cardiol2005;95(2):304-307.
  • Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, lskandrian AE. Effect of caffeine on ischemia detection by adenosine SPECT perfusion imaging. JAm Coli Cardiel 2006;47(11):2296-2302.
  • Aqel RA, Hage, FG, Zoghbi GJ, Tallaj JA, Misra VK, Bourge RC, MD The Safety of Bivalirudin during Elective Percutaneous Coronary Interventions in Heart Transplant Patients.. Cardiel J 2007;14:458-462.
  • Aqel R*, Zoghbi GJ*, Bender LW, Scott JW, Baldwin JA, Heo J, lskandrian AE. Myocardial perfusion imaging after transient balloon occlusion during percutaneous coronary interventions. J Nucl Cardiel 2007;14(2):221-228. [*contributed equally to this work]
  • Patel K, Gupta H, Nath H, Aqel R, Zoghbi GJ, Soto B, Lloyd SG. Origin of all three major coronary arteries from separate ostia in the right sinus of Valsalva: clinical, angiographic and MRI findings and incidence in a referral population. Catheter Cardiovas lnterven 2007;69(5):711-718.
  • Hage FG, Smallheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, lskandrian AE, de Mattos AM, Aqel RA. Predictors of survival in patients with endstage renal disease evaluated for kidney transplantation. Am J Cardiel 2007;100:1020-1025.
  • Aqel RA*, Zoghbi GJ*, Hage FG, Dell'ltallia, lskandrian AE. Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc lnterv 2008;72:479-485. [*contributed equally to this work]
  • Aqel RA*, Zoghbi GJ*, Hage FG, Philips G, Perry G, lskandrian AE, Dell'ltallia L. Feasibility of primary clot extraction prior to percutaneous coronary intervention in acute myocardial infarction. Catheter Cardiovasc lnterv 2008;71:870-876. [* contributed equally to this work]
  •  Aqel RA*, Zoghbi GJ*, Hage FG, Dell'ltalia L. Three-dimensional balloon catheter sizing identifies significant underdeployed stents using conventional methods in renal artery interventions. J Invasive Cardiol 2008;20:270-276. [*contributed equally to this work]
  • Aqel R, Hage FG, Zoghbi GJ, Tabereaux P, Heo J, Perry G, Epstein A, Dell' ltalia L, lskandrian A. Serial changes in infarct size after alcohol septal ablation in hypertrophic cardiomyopathy: correlation with clinical status and pressure gradients. Am J Cardiol2008;101:1328-1333.
  •  Zoghbi GJ, Goyal M, Hage F, Myers RP, Papapietro SE, Brott BC, Misra VK, lskandrian AE, Hillegass WB. Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions. J Invasive Cardiol 2009:21;34-39.
Published Peer-Reviewed Review Articles
  • Aqel RA, Zoghbi GJ, lskandrian AE. Spontaneous coronary artery dissection, aneurysms and pseudoaneurysms: A review. Echocardiography 2004;21(2):175- 172.
  • Zoghbi GJ, lskandrian AE. Adenosine myocardial perfusion imaging. Curr Med lmag Rev. 2006;2(3):315-327.
  • Aqel RA, Hage FG, Cogar B, Burri M, Wells B, Allison S, Zoghbi GJ, Perry G, Bittner V, Fan P, NandaN. Transthoracic echocardiography guided procedures in the catheterization laboratory. Echocardiography 2007;24:1000-1007.
  • Zoghbi GJ*, Dorfman TA*, lskandrian AE. State-Of-The-Art Paper: the effects of medications on myocardial perfusion. J A Coli Cardiol 2008;52:401-416. [* contributed equally to this work]
  • Hage FG*, Venkataraman R*, Zoghbi GJ*, Perry GJ, De Mattos AM, lskandrian, AE. The scope of cardiovascular disease in patients with chronic kidney disease. J A Coli Cardiol2009:53;2129-40. [*contributed equally to this work]
  • Zoghbi GJ, lskandrian AE. Regadenoson myocardial perfusion imaging. Imaging Med 2010;2:395-406.
  •  Hillegass WB, Brott BC, Dobbs JC, Misra VK, Zoghbi GJ. Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview. Vase Health Risk Manag 2011;7: 4746-4761.
  • Zoghbi GJ, Iskandrian AE. Selective adenosine agonists and myocardial perfusion imaging. J Nucl Cardiol 2012;19:126-141.
Published Peer-Reviewed Case Reports
  • Zoghbi GJ, lskandrian AE. Evaluation of patients with ST elevation myocardial infarction. American College of Cardiology case studies (Published online 5/13/03). http://www.cardiosource.com/study/case_studies (Noninvasive cardiology)
  • Zoghbi GJ, lskandrian AE. Evaluation of patients with chest pain syndromes after CABG. American College of Cardiology case studies (Published online 1/25/02). http://www.cardiosource.com/study/case_studies (Noninvasive cardiology)
  • Nekkanti R, Nanda NC, Zoghbi GJ, Mukhtar 0, McGiffin DC. Transesophageal two and three-dimensional echocardiographic diagnosis of combined left ventricular pseudoaneurysm and ventricular septal rupture. Echocardiography 2002;19(4):345-349.
  • Zoghbi GJ, Nanda NC, Baweja G. Transesophageal and transpharyngeal echocardiographic detection of the extracranial segments of the left vertebral artery. Am J Geriatr Cardiol2003;12(2):113-116.
  • Hillegass W, Zoghbi GJ, Pandey A, Misra V, Chapman G, Brott B. Treatment of in-stent restenosis in a gastroepiploic artery coronary bypass graft with brachytherapy. J invasive Cardiol 2003;15(11):677-680.
  • Zoghbi GJ, Heo J, lskandrian AE. Hiatal hernia detected by Tc-99m tetrofosmin SPECT. J Nucl Cardiol2003;10(6):712-713.
  • Zoghbi GJ, Misra V, Chapman G, Hillegass W, Brott B, Aqel R, Bourge R Long term follow up of brachytherapy for treatment of allograft in-stent restenosis. Catheter Cardiovasc lnterven 2004;61(2):217-221.
  • Aqel R, Zoghbi GJ, lskandrian A. Spontaneous coronary artery dissection with pseudoaneurysm formation diagnosed by intravascular ultrasound: A case report. Echocardiography 2004;21(2):153-157.
  • Aqel R, Gupta R, Tallaj J, Zoghbi GJ. Restenosis of a siro/imus-coated stent in a heart transplant recipient with allograft vasculopathy. J Heart Lung Transplant 2005;24(9):1444.e9-1444.e11.
  • Aqel R, Gupta R, Zoghbi G. Coexistent fibromuscular dysplasia and atherosclerotic renal artery stenosis. J invasive Cardiol 2005;17(10):572-573.
  • Aqel R, Gupta R, Zoghbi GJ. Thebesian venous lake. Heart 2005;91(10):1318.
  • Aqel R, Dobbs J, Lau Y, Lloyd S, Gupta H, Zoghbi GJ. Transjugular biopsy of a right atrial mass under intracardiac echocardiographic guidance. J Am Soc Echocardiogr 2006;19(8):1072 e5-e8.
  • Aqel RA, Gupta R, Zoghbi GJ. Systolic compression of bypass grafts. J Invasive Cardioi2006;18(5):E162-E165.
  • Aqel R, Mehta D, Zoghbi GJ. Percutaneous balloon pericardiotomy for the treatment of infected pericardia/ effusion with tamponade. J Invasive Cardiol 2006;18(7):E194-E197.
  • Aqel R, Gupta R, Zoghbi GJ. Brachytherapy for renal artery in-stent restenosis. J Invasive Cardioi2006;18(8):E227-E229.
  • Aqel R, Lloyd S, Gupta H, Zoghbi GJ. Three vessel coronary artery disease, aortic stenosis, and constrictive pericarditis presenting as recurrent symptomatic pleural effusion 27 years after radiation therapy. Heart Surg Forum 2006;9(4):E728-E730.
  • Aqel R, Gupta R, Zoghbi GJ. A novel method of clot extraction using a FilterWire EX in acute myocardial infarction. J Invasive Cardioi2007;19:E104-E106.
  • Aqel R, Hage F, Zoghbi GJ. Percutaneous aortic valvuloplasty as a bridge to a high risk percutaneous coronary intervention. J Invasive Cardiol 2007;19:E238- E241.
  • Zoghbi GJ, Saddekni S, Misra V. Saphenous vein graft to left atrium fistula treated with percutaneous transcatheter embolization with coils. J Invasive Cardiol 2007;19:E331-E334.
  • Hage FG, Bravo PE, Zoghbi GJ, Bynon JS, Aqel RA. Hypertrophic obstructive cardiomyopathy in liver transplant patients. Cardiol J 2008;15:74-79.
  • Hage FG, Zoghbi GJ, Aqel RA, Nanda NC. Subaortic stenosis missed by invasive hemodynamic assessment. Echocardiography 2008:25:1007-1010.
Published Letters to the Editor
  • Aqel R, Zoghbi GJ. Radiation induced cardiac disease. J Heart Lung Transplant. 2006;25(2):257-258.
  • Zoghbi GJ, lskandrian AE. Reply to "one" Starbucks coffee and nuclear SPECT to go. J Am Coli Cardiol 2007;49:528-529.
Manuscripts Submitted for Publication
  • Zoghbi GJ, Misra VK, Brott BC, Papapietro SE, Dai D, Ou F, Wang TW, Klein LW, Messenger JC, Hillegass WB. Acute myocardial infarction and left main culprit lesions: contemporary percutaneous coronary interventions outcomes: a report from the NCDR CathPCI Registry. (submitted to JAm Coli Cardiollntv, under review)
Manuscripts Under Preparation
  • Reassessment of the validity of the universal definition for Ml following coronary revascularization. (SCAI, in progress)
  • SCAI radial best practices statement. (SCAI, in progress)
  • Zoghbi GJ, Brott B, Misra V, Hillegass W. Depressed left ventricular function carries a worse in-hospital outcome in patients undergoing rotational atherectomy.
Book Chapters
  • Zoghbi GJ, lskandrian AE. Coronary artery disease detection: pharmacologic stress. Zaret B, Beller G, editors. Clinical Nuclear Cardiology: State of the Art and Future Directions. 3rd edition. Elsevier Science, Inc. 2005, Chapter 14, 233-253.
  • Zoghbi GJ, lskandrian AE. Treadmill exercise testing. lskandrian AE, Garcia E, editors. Nuclear Cardiac Imaging: Principles and Applications. 4th edition. Oxford University Press. 2008, Chapter 14, 241-266.
  • Zoghbi GJ, lskandrian AE. Exercise myocardial perfusion imaging. lskandrian AE, Garcia EV, editors. Nuclear Cardiac Imaging: Principles and Applications. 4th edition. Oxford University Press. 2008, Chapter 15, 267-292.
  • Zoghbi GJ, lskandrian AE. Pharmacological stress testing. lskandrian AE, Garcia EV, editors. Nuclear Cardiac Imaging: Principles and Applications. 4th edition. Oxford University Press. 2008, Chapter 16, 293-315.
  • Zoghbi GJ, lskandrian AE. Screening asymptomatic patients for coronary artery disease. lskandrian AE, Garcia E, editors. Nuclear Cardiac Imaging: Principles and Applications. 4th edition. Oxford University Press. 2008, Chapter 34, 631-660.
  • Zoghbi GJ, lskandrian AE. Coronary artery disease detection: pharmacologic stress SPECT. Zaret B, Beller G, editors. Clinical Nuclear Cardiology: State of the Art and Future Directions. 4rd edition. Elsevier Science, Inc. 2010, Chapter 15, 244-266.
  • Zoghbi GJ, Hillegass WB. Adjunctive pharmacology during percutaneous coronary intervention. Baliga R, editor. Cardiology Board Review. Chapter 44. (In press)
  • Zoghbi GJ, lskandrian AE. Stress approaches for myocardial perfusion imaging. Bergman S, editor. Cardiac Imaging: The Clinical Guide. Humana Press, Inc, 2010. (In press)
  • Zoghbi GJ, Iqbal FM, lskandrian AE. Choice of stress test. lskandrian AE, Garcia M, editors. Atlas of Nuclear Cardiology: An Imaging Companion to Braunwald's Heart Disease. Elsevier Science, Inc. 2011, Chapter 5, 117-143.
  • Zoghbi GJ, Dubovsky EV, lskandrian AE. Use in stable patients with known or suspected coronary artery disease. lskandrian AE, Garcia M, editors. Atlas of Nuclear Cardiology: An Imaging Companion to Braunwald's Heart Disease. Elsevier Science, Inc. 2011, Chapter 6, 144-161.
  • Zoghbi GJ, Dubovsky EV, lskandrian AE. Patients with PC/ and CABG. lskandrian AE, Garcia M, editors. Atlas of Nuclear Cardiology: An Imaging Companion to Braunwald's Heart Disease. Elsevier Science, Inc. 2011, Chapter 8, 185-203.
  • Zoghbi GJ, Heo J, lskandrian AE. Patients with Acute Coronary Syndrome. lskandrian AE, Garcia M, editors. Atlas of Nuclear Cardiology: An Imaging Companion to Braunwald's Heart Disease. Elsevier Science, Inc. 2011, Chapter 9, 204-217.
Published Abstracts
  • Zoghbi GJ, Misra VK, Brott BC, Papapietro SE, Dai D, Ou F, Wang TW, Klein LW, Messenger JC, Hillegass WB. Non ST elevation myocardial infarction and left main culprit lesions: contemporary percutaneous coronary interventions outcomes: a report from the NCDR CathPCI Registry. Catheter Cardiovasc lnterven 2010;75:S110.
  • Zoghbi GJ, Misra VK, Brott BC, Papapietro SE, DiaD, Ou F, Wang TW, Klein LW, Messenger JC, Hillegass WB. ST elevation myocardial infarction due to left main culprit lesions: percutaneous coronary intervention outcomes, on behalf of the ACC-NCDR CathPC/ Registry Participating Centers. JAm Coli Cardiol 2010;55:A183.
  • Hillegass WB, Ershadi RE, Mayhew MA, Misra VK, Papapietro SE, Brott BC, Zoghbi GJ. Hyperglycemia and contrast-induced acute kidney injury: threshold for injury. JAm Coli Cardioi2010;55:A211.
  • Hillegass WB, Misra VK, Brott BC, Messenger JC, Klein LW, Wang TW, Papapietro SE, DiaD, Ou F, Zoghbi GJ. Left main culprit lesion myocardial infarction in patients with prior coronary artery bypass grafting: percutaneous coronary artery intervention outcomes, on behalf of the ACC-NCDR CathPC/ Registry Participating Centers. J Am Coli Cardiol 2010;55:A196.
  • Zoghbi GJ, Brott B, Misra V, Hillegass W. Depressed left ventricular function carries a worse in-hospital outcome in patients undergoing rotational atherectomy. Catheter Cardiovasc lnterven 2009;73:S21-S22.
  • Sweeney AW, Hage F, Aqel R, Phillips G, Perry G, Zoghbi G, Calhoun D. Percutaneous renal artery revascu/arization versus medical therapy for renal artery stenosis: A prospective randomized trial. J Am Coli Cardiol 2009;53;A87.
  • Suarez A, Zoghbi G, Rajdev S, Brott BC, Aqel R, Misra V. ln-hopsital outcomes of rotational atherectomy in a large cohort of patients with depressed left ventricular function. Catheter Cardiovasc lnterven 2007:69:S21.
  • Hage FG, Smalheiser S, Zoghbi GJ, Perry G, lskandrian AE, de Mattos AM, Aqel RA. Left ventricular function rather than coronary anatomy predicts survival in patients with end stage renal disease. J Am Coli Cardiol 2007:49;367A.
  • Gupta H, Denney TS, Lloyd SG, Calhoun D, Zoghbi GJ, Corros C, Nagaraj H, Dell'ltalia L. Effects of loading conditions on the left ventricular mechanics. J Cardiovasc Magn Reson Imaging 2007;9:417-418.
  • Zoghbi GJ, Goyal MK, Hage FG, Patel NJ, Brott BC, Misra VK, Myers PR, Hillegass WB. Prophylactic sodium nitroprusside administration in saphenous vein graft intervention reduces post-procedural cardiac marker elevation. Circulation 2006:114(18);Supplement 11-786.
  • Smalheiser S, Hage F, De Mattos AM, Zoghbi G, Perry G, lskandrian AE, Aqel RA. Systolic left ventricular dysfunction is a stronger predictor of mortality than perfusion pattern in end-stage renal disease. Circulation 2006:114(18);Supplement 11-368.
  • Smalheiser S, Hage F, De Mattos AM, Zoghbi G, Perry G, lskandrian AE, Aqel RA. Diabetes mellitus and systolic dysfunction in end-stage renal disease. Circulation 2006:114(18);Supplement 11-871.
  • Hage FG, Smalheiser S, de Mattos AM, Zoghbi G, Perry G, Jskandrian A, Curtis J, Gaston R, Aqel R. Coronary angiography and revascularization fail to predict and impact survival in patients with end stage renal disease. J Am Soc Nephrol 2006;17: 348A.
  • Hillegass WB, Lyerly ML, Patel NJ, Zoghbi GJ, Misra VK, Brott BC. Frequency and predictors of post-procedural myonecrosis in saphenous vein graft intervention in the stent era: a meta-regression. Circulation 2006:114(18);Supplement 11-733.
  • Ershadi RE, Mayhew MW, Mirza S, Zoghbi GJ, Kelly AK, Misra VK, Brott BC, Hillegass. Exacerbation or development of hyperglycemia predicts peri-procedural nephropathy. Circulation 2006:114(18);Supplement 11-872.
  • Ershadi RE, Mayhew MW, Mirza S, Zoghbi GJ, Brott BC, Hillegass WB. Hyperglycemia predicts contrast-induced renal dysfunction. Catheter Cardiovasc lnterven 2006:67(5);737.
  • Zoghbi GJ, Goyal MK, Hage FG, Patel NJ, Brott BC, Misra VK, Myers PR, Hillegass WB. Prophylactic nitroprusside administration in saphenous vein graft intervention reduces the risk of periprocedural myonecrosis. Catheter Cardiovasc lnterven 2006:67(5);800.
  • Gupta R, Aqel RA, Mehta D, Clay MA, Zoghbi G, lskandrian AE. Distribution of resting perfusion defects in hypertrophic cardiomyopathy. J Nucl Cardiol 2005:12(4);8120.
  • Mehta D, Aqel RA, Zoghbi GJ, Heo J, lskandrian AE. SPECT myocardial perfusion imaging in hypertrophic cardiomyopathy patients after alcohol septal ablation. J Nucl Cardiel 2005:12(4);S121.
  • Sanderson B, Zoghbi G, Bittner V. A comparison of comorbidity indexes and their classification of patients with coronary artery disease enrolled in cardiac rehabilitation. J Cardiopulm Rehabil 2005;25:293.
  • Vengala S, Misra V, Zoghbi GJ, Ahmed S, Mehmood F, Patel V. Early outcomes of rotational atherectomy in relation to left ventricular function. Cardiovasc Revascul Med (in press).
  •  Zoghbi GJ, Htay T, Aqel R, Blackmon L, Heo J, lskandrian A. Effect of caffeine on ischemia detection by adenosine SPECT perfusion imaging. Circulation 2004;110(17):Supplement 111-684.
  • Zoghbi GJ, Aqel RA, Trimm J, Baldwin S, lskandrian AE. Effect of caffeine on · farctional flow reserve. J Am Coli Cardiel 2004;43(5):Supplement A 368A-369A.
  • Mirza S, Sanderson B, Zoghbi GJ, Bittner V.Comparison of baseline characteristics and outcomes in caucasian versus african-american patients undergoing cardiac rehabilitation. J Cardiopulm Rehabil 2003;23(5):370-371.
  • Zoghbi G, Ellis P, Heo J, lskandrian A. Left anterior descending artery perfusion patterns. J Nucl Cardiel 2003;10(4):S23.
  • Ershadi R, Zoghbi G, Patel Amar, Heo J, Bynon S, lskandrian A. Outcome of patients after liver transplantation: prognostic role of stress perfusion imaging. J Nucl Cardioi2003;10(4):S23-S24.
  • Baweja G, Mehta D, Venkataraman R, Heo J, Nanda NC, lskandrian AE, Zoghbi G, Dod H. Relationship between adenosine-induced and endothelial-dependent changes in brachial artery reactivity. J Nucl Cadioi2003;10(4):S4.
  • Abo-Auda W, Zoghbi G, Patel A, Hillegass W. lnterventional strategy in reducing cardiac enzyme elevations after percutaneous interventions of saphenous vein grafts. Am J Cardioi2002;105H-106H.
  • Abo-Auda W, Zoghbi G, Patel A, Hillegass W. Thromboatherectomy during percutaneous saphenous vein graft intervention improves graft patency. Am J Cardioi2002;106H.
  • Zoghbi G, Sanderson B, Redden 0, Bittner V. Temporal trends in risk characteristics among patients enrolled in cardiac rehabilitation. J Cardiopulm Rehabil 2002;22:359.
  • Benza R, Brown R, Kirklin J, Hubbard M, Zoghbi G, McGiffin D, Bourge R, Foley B. Palliation of allograft vasculopathy with transluminal angioplasty- a decade of experience. J Heart Lung Transplant 2002;21:74-75.
  • Zoghbi G, Sanderson B, Breland J, Adams C, Schumann C, Bittner V. Risk stratification in cardiac rehabilitation. Circulation 2001;104:11-799.
  • Donabedian M, Paolocci N, Varghese P, Zoghbi G, Vandegaer R, Hare J. Johns Hopkins Univ. Insulin enhances nitric oxide attenuation of f3- adrenergic stimulated myocardial contractility. Circulation 2000; 102:503.
Poster Exhibits
  • Maryland ACP regional meeting, Baltimore, Maryland, 5/13/1999. The effect of glibenclamide on the contractility of hyperadrenergic isolated rat hearts.
  • Association of Program Directors of Internal Medicine, Philadelphia, Pennsylvania, 4/11/2000. Handheld computers in an internal medicine residency: effects on sign outs.
  • Maryland ACP regional meeting, Baltimore, Maryland, 5/11/2000. Handheld computers in an internal medicine residency: effects on sign outs. (Winner of the second scientific poster prize)
  • American Heart Association Scientific Sessions, Anaheim, California, 11/14/2001. Risk stratification in cardiac rehabilitation.
  • American College of Cardiology, Alabama Chapter. Sandestin, Florida, 5/31/02. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. (one of five finalist posters presented in the meeting)
  • Transcatheter Cardiovascular Therapeutics Annual Meeting, Washington DC, 9/24/02. lnterventional strategy in reducing cardiac enzyme elevations after percutaneous interventions of saphenous vein grafts. Thromboatherectomy during percutaneous saphenous vein graft intervention improves graft patency.
  • American Society of Nuclear Cardiology 2003 ath Annual Symposium and Scientific Session, Indianapolis, Indiana, 9/12/03. Left anterior descending artery perfusion patterns. Outcome of patients after liver transplantation: prognostic role of stress perfusion imaging.
  • American College of Cardiology 53rd Annual Scientific Session, New Orleans, Louisiana, 3/9/04. Effect of caffeine on fractional flow reserve.
  • Society for Cardiovascular Angiography and Interventions, 29th Annual Scientific Sessions, Chicago, Illinois, 5/12/06. Prophylactic nitroprusside administration in saphenous vein graft intervention reduces the risk of periprocedural myonecrosis.
  • American Heart Association Scientific Sessions 2006, Chicago, Illinois, 11/15/2006. Prophylactic sodium nitroprusside administration in saphenous vein graft intervention reduces post-procedural cardiac marker elevation.
  • Society for Cardiovascular Angiography and Interventions, 32nd Annual Scientific Sessions, Las Vegas, Nevada, 5/6/2009. Depressed left ventricular function carries a worse in-hospital outcome in patients undergoing rotational atherectomy.
  • Society for Cardiovascular Angiography and Interventions, 33rd Annual Scientific Sessions, San Diego, California, 5/6/2010. Non ST elevation myocardial infarction and left main culprit lesions: contemporary percutaneous coronary interventions outcomes: a report from the NCDR CathPCI Registry.
Oral Presentations

Scientific papers presented at national meetings:

  • American Association of Cardiovascular and Pulmonary Rehabilitation 17th Annual Meeting, Charlotte, North Carolina, 9/27/02. Temporal trends in risk characteristics among patients enrolled in cardiac rehabilitation.
  • American Society of Nuclear Cardiology 9th Annual Scientific Session, New York, New York. ASNC / Amersham Health Award for Clinical Research in Nuclear Cardiology Presentation, 10/3/04. Effect of caffeine on ischemia detection by adenosine SPECT perfusion imaging. (Oral presentation)
  • American Heart Association Scientific Sessions 2004, New Orleans, Louisiana, 11/10/04. Effect of caffeine on ischemia detection by adenosine SPECT perfusion imaging. (Oral presentation)
  • Northwestern Cardiovascular Young Investigators’ Forum (finalist) Northwestern University, Chicago, Illinois, 10/1/2006. Effects of loading conditions on left ventricular mechanics. (Oral presentation)
  • American College of Cardiology 59th Annual Scientific Sessions, Atlanta, Georgia, 3/15/2010. ST elevation myocardial infarction due to left main culprit lesions: percutaneous coronary intervention outcomes.

Home | Medical Services | Patient Education | Our Physicians | About Stern | Contact Us | Feedback | Privacy Statement
Allscripts link from Hospital


All Rights Reserved. Copyright 2006 The Stern Cardiovascular Foundation, P.A.
Stern Cardiovascular Foundation Website Developers